Filing Flows › Ardelyx (ARDX) › Recalls, complaints & regulation
Ardelyx (ARDX): clinical trials
Ardelyx (ARDX) beyond its filings: 2 active clinical trials.
Ardelyx's latest quarter
Ardelyx, Q3 2026: revenue $128M (+16% year over year), operating margin 3.2%, net loss $737K, operating cash flow $2.2M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Ardelyx have?
2 active studies on ClinicalTrials.gov, 2 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.